What is Alnylam (ALNY)?
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development, and commercialization of RNA interference (RNAi) therapeutics. The company utilizes RNAi technology to develop treatments aimed at silencing specific genes that cause or contribute to various diseases. Alnylam's pipeline includes therapies targeting rare genetic disorders, cardiometabolic diseases, and hepatic infectious diseases. The company engages in extensive research and development activities to advance its product candidates through clinical trials and regulatory approval processes. Alnylam collaborates with academic institutions, biotechnology firms, and pharmaceutical companies to enhance its scientific capabilities and expand its therapeutic reach. Headquartered in the United States, the company operates with a global perspective, aiming to address unmet medical needs through innovative genetic medicine. Its approach represents a novel mechanism of action distinct from traditional small molecule or antibody therapies. Alnylam's work contributes to the broader field of genetic medicine and RNA-based therapeutics, which has seen increasing interest for its potential to treat a variety of complex diseases.
Alnylam Stock Price Today: Live Overview
The price today is shaped by market activity, with Alnylam currently at $312.31. During today's session, it has traded between $307.87 and $322.06, showing a daily change of 0%.
FAQ: Alnylam (ALNY)
What is the current price of ALNY stock?
Alnylam is trading at $312.31.
Does ALNY pay dividends?
Alnylam pays dividends to shareholders.
Does ALNY have a formal corporate presence or regional headquarters in the UAE?
Alnylam does not have an official office or subsidiary in the UAE and operates through partners.
What is ALNY best known for?
Alnylam is most famous for its RNA interference therapeutics.
What assets are typically shown together with ALNY?
Commonly shown alongside ALNY: Arrowhead Pharma, Novavax Inc, United Therapeutics Corp
Latest shares articles



